Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Net Margin: 2021-2025

Historic Net Margin for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to -0.19%.

  • Immunocore Holdings' Net Margin fell 1108.00% to -0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was -7.71%, marking a year-over-year increase of 818.00%. This contributed to the annual value of -16.47% for FY2024, which is 570.00% up from last year.
  • According to the latest figures from Q3 2025, Immunocore Holdings' Net Margin is -0.19%, which was up 98.20% from -10.51% recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Net Margin registered a high of 10.89% during Q3 2024, and its lowest value of -590.90% during Q4 2021.
  • Over the past 3 years, Immunocore Holdings' median Net Margin value was -15.42% (recorded in 2024), while the average stood at -14.88%.
  • The largest annual percentage gain for Immunocore Holdings' Net Margin in the last 5 years was 4,003bps (2025), contrasted with its biggest fall of 1,108bps (2025).
  • Immunocore Holdings' Net Margin (Quarterly) stood at -590.90% in 2021, then reached -28.12% in 2023, then dropped by 16bps to -28.28% in 2024, then crashed by 1,108bps to -0.19% in 2025.
  • Its Net Margin stands at -0.19% for Q3 2025, versus -10.51% for Q2 2025 and 5.31% for Q1 2025.